Nonprofit foundations spur translational research

Trends Pharmacol Sci. 2014 Nov;35(11):552-5. doi: 10.1016/j.tips.2014.09.003. Epub 2014 Oct 29.

Abstract

Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.

MeSH terms

  • Drug Discovery / methods*
  • Humans
  • Neurodegenerative Diseases / drug therapy
  • Organizations, Nonprofit*
  • Pharmacology / methods*
  • Translational Research, Biomedical*